nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2B6—Ifosfamide—testicular cancer	0.13	0.187	CbGbCtD
Primidone—CYP2C8—Ifosfamide—testicular cancer	0.0982	0.142	CbGbCtD
Primidone—CYP2C19—Ifosfamide—testicular cancer	0.0824	0.119	CbGbCtD
Primidone—CYP2C9—Ifosfamide—testicular cancer	0.0685	0.0988	CbGbCtD
Primidone—CYP2B6—Cisplatin—testicular cancer	0.0631	0.0909	CbGbCtD
Primidone—CHRFAM7A—corpus luteum—testicular cancer	0.057	0.413	CbGeAlD
Primidone—CYP2C8—Etoposide—testicular cancer	0.047	0.0677	CbGbCtD
Primidone—CHRNA7—corpus luteum—testicular cancer	0.046	0.333	CbGeAlD
Primidone—CYP2B6—Doxorubicin—testicular cancer	0.0423	0.0609	CbGbCtD
Primidone—CYP3A4—Ifosfamide—testicular cancer	0.0398	0.0574	CbGbCtD
Primidone—CYP1A2—Etoposide—testicular cancer	0.0363	0.0524	CbGbCtD
Primidone—CYP2C9—Cisplatin—testicular cancer	0.0333	0.048	CbGbCtD
Primidone—CYP3A4—Vinblastine—testicular cancer	0.0211	0.0305	CbGbCtD
Primidone—CYP3A4—Etoposide—testicular cancer	0.019	0.0274	CbGbCtD
Primidone—Muscle contracture—Dactinomycin—testicular cancer	0.018	0.107	CcSEcCtD
Primidone—CYP3A4—Doxorubicin—testicular cancer	0.013	0.0187	CbGbCtD
Primidone—GRIA2—embryo—testicular cancer	0.00661	0.0479	CbGeAlD
Primidone—Anaemia megaloblastic—Methotrexate—testicular cancer	0.00513	0.0305	CcSEcCtD
Primidone—Nystagmus—Vinblastine—testicular cancer	0.00496	0.0295	CcSEcCtD
Primidone—Eruption—Dactinomycin—testicular cancer	0.00453	0.027	CcSEcCtD
Primidone—CHRFAM7A—female gonad—testicular cancer	0.00332	0.0241	CbGeAlD
Primidone—GRIA2—testis—testicular cancer	0.00323	0.0234	CbGeAlD
Primidone—GABRA5—testis—testicular cancer	0.00303	0.022	CbGeAlD
Primidone—CHRFAM7A—testis—testicular cancer	0.00295	0.0214	CbGeAlD
Primidone—GABRA3—testis—testicular cancer	0.00282	0.0204	CbGeAlD
Primidone—CHRNA7—female gonad—testicular cancer	0.00268	0.0194	CbGeAlD
Primidone—Ataxia—Chlorambucil—testicular cancer	0.00264	0.0157	CcSEcCtD
Primidone—CHRNA7—testis—testicular cancer	0.00238	0.0172	CbGeAlD
Primidone—GABRB2—testis—testicular cancer	0.0023	0.0167	CbGeAlD
Primidone—Depression—Vinblastine—testicular cancer	0.00197	0.0117	CcSEcCtD
Primidone—Eruption—Methotrexate—testicular cancer	0.00197	0.0117	CcSEcCtD
Primidone—Agranulocytosis—Vinblastine—testicular cancer	0.00185	0.011	CcSEcCtD
Primidone—Eruption—Epirubicin—testicular cancer	0.00184	0.0109	CcSEcCtD
Primidone—Psychotic disorder—Ifosfamide—testicular cancer	0.00181	0.0108	CcSEcCtD
Primidone—Eruption—Doxorubicin—testicular cancer	0.0017	0.0101	CcSEcCtD
Primidone—CYP2B6—gonad—testicular cancer	0.00166	0.012	CbGeAlD
Primidone—Nystagmus—Epirubicin—testicular cancer	0.00158	0.00942	CcSEcCtD
Primidone—Anaemia—Chlorambucil—testicular cancer	0.00156	0.00928	CcSEcCtD
Primidone—GABRA2—lymph node—testicular cancer	0.00152	0.011	CbGeAlD
Primidone—Nystagmus—Doxorubicin—testicular cancer	0.00147	0.00871	CcSEcCtD
Primidone—Agranulocytosis—Dactinomycin—testicular cancer	0.00146	0.00865	CcSEcCtD
Primidone—Anaemia—Vinblastine—testicular cancer	0.00143	0.0085	CcSEcCtD
Primidone—Vertigo—Vinblastine—testicular cancer	0.00139	0.00827	CcSEcCtD
Primidone—Blood disorder—Epirubicin—testicular cancer	0.00135	0.00805	CcSEcCtD
Primidone—CYP2C8—testis—testicular cancer	0.00134	0.00967	CbGeAlD
Primidone—Agranulocytosis—Ifosfamide—testicular cancer	0.00133	0.00793	CcSEcCtD
Primidone—Anorexia—Chlorambucil—testicular cancer	0.00131	0.00781	CcSEcCtD
Primidone—Connective tissue disorder—Ifosfamide—testicular cancer	0.00126	0.0075	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—testicular cancer	0.00125	0.00745	CcSEcCtD
Primidone—Visual impairment—Ifosfamide—testicular cancer	0.00124	0.00735	CcSEcCtD
Primidone—Anaemia—Bleomycin—testicular cancer	0.00121	0.00718	CcSEcCtD
Primidone—Anorexia—Vinblastine—testicular cancer	0.0012	0.00716	CcSEcCtD
Primidone—Eye disorder—Ifosfamide—testicular cancer	0.0012	0.00713	CcSEcCtD
Primidone—Decreased appetite—Chlorambucil—testicular cancer	0.0012	0.00712	CcSEcCtD
Primidone—CYP2B6—testis—testicular cancer	0.0012	0.00868	CbGeAlD
Primidone—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00119	0.00707	CcSEcCtD
Primidone—Fatigue—Chlorambucil—testicular cancer	0.00119	0.00706	CcSEcCtD
Primidone—Anaemia—Dactinomycin—testicular cancer	0.00113	0.0067	CcSEcCtD
Primidone—Mental disorder—Ifosfamide—testicular cancer	0.00112	0.00668	CcSEcCtD
Primidone—Malnutrition—Ifosfamide—testicular cancer	0.00112	0.00664	CcSEcCtD
Primidone—Decreased appetite—Vinblastine—testicular cancer	0.0011	0.00653	CcSEcCtD
Primidone—Connective tissue disorder—Cisplatin—testicular cancer	0.00109	0.00646	CcSEcCtD
Primidone—Visual impairment—Cisplatin—testicular cancer	0.00107	0.00634	CcSEcCtD
Primidone—Agranulocytosis—Etoposide—testicular cancer	0.00105	0.00626	CcSEcCtD
Primidone—Eye disorder—Cisplatin—testicular cancer	0.00103	0.00615	CcSEcCtD
Primidone—Anaemia—Ifosfamide—testicular cancer	0.00103	0.00614	CcSEcCtD
Primidone—Anorexia—Bleomycin—testicular cancer	0.00102	0.00605	CcSEcCtD
Primidone—Vertigo—Ifosfamide—testicular cancer	0.001	0.00597	CcSEcCtD
Primidone—Asthenia—Chlorambucil—testicular cancer	0.000989	0.00588	CcSEcCtD
Primidone—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000972	0.00578	CcSEcCtD
Primidone—Malnutrition—Cisplatin—testicular cancer	0.000963	0.00573	CcSEcCtD
Primidone—Arthralgia—Ifosfamide—testicular cancer	0.000951	0.00565	CcSEcCtD
Primidone—Anorexia—Dactinomycin—testicular cancer	0.000948	0.00564	CcSEcCtD
Primidone—Eye disorder—Etoposide—testicular cancer	0.000947	0.00563	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000945	0.00562	CcSEcCtD
Primidone—Decreased appetite—Bleomycin—testicular cancer	0.000927	0.00551	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—testicular cancer	0.000926	0.00551	CcSEcCtD
Primidone—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000906	0.00539	CcSEcCtD
Primidone—Asthenia—Vinblastine—testicular cancer	0.000906	0.00539	CcSEcCtD
Primidone—Nervous system disorder—Ifosfamide—testicular cancer	0.000894	0.00532	CcSEcCtD
Primidone—Anaemia—Cisplatin—testicular cancer	0.00089	0.00529	CcSEcCtD
Primidone—Skin disorder—Ifosfamide—testicular cancer	0.000886	0.00526	CcSEcCtD
Primidone—Vomiting—Chlorambucil—testicular cancer	0.000876	0.00521	CcSEcCtD
Primidone—Anorexia—Ifosfamide—testicular cancer	0.000869	0.00517	CcSEcCtD
Primidone—Decreased appetite—Dactinomycin—testicular cancer	0.000865	0.00514	CcSEcCtD
Primidone—Fatigue—Dactinomycin—testicular cancer	0.000858	0.0051	CcSEcCtD
Primidone—Dizziness—Vinblastine—testicular cancer	0.000835	0.00497	CcSEcCtD
Primidone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000831	0.00494	CcSEcCtD
Primidone—Ataxia—Methotrexate—testicular cancer	0.000825	0.00491	CcSEcCtD
Primidone—Diplopia—Epirubicin—testicular cancer	0.000821	0.00488	CcSEcCtD
Primidone—Nausea—Chlorambucil—testicular cancer	0.000819	0.00487	CcSEcCtD
Primidone—Anaemia—Etoposide—testicular cancer	0.000815	0.00485	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000814	0.00484	CcSEcCtD
Primidone—Somnolence—Ifosfamide—testicular cancer	0.000811	0.00482	CcSEcCtD
Primidone—Vomiting—Vinblastine—testicular cancer	0.000803	0.00477	CcSEcCtD
Primidone—Vertigo—Etoposide—testicular cancer	0.000793	0.00471	CcSEcCtD
Primidone—Decreased appetite—Ifosfamide—testicular cancer	0.000793	0.00471	CcSEcCtD
Primidone—Headache—Vinblastine—testicular cancer	0.000791	0.0047	CcSEcCtD
Primidone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000787	0.00468	CcSEcCtD
Primidone—Fatigue—Ifosfamide—testicular cancer	0.000786	0.00467	CcSEcCtD
Primidone—Ataxia—Epirubicin—testicular cancer	0.000772	0.00459	CcSEcCtD
Primidone—Nervous system disorder—Cisplatin—testicular cancer	0.000771	0.00458	CcSEcCtD
Primidone—Asthenia—Bleomycin—testicular cancer	0.000765	0.00455	CcSEcCtD
Primidone—Skin disorder—Cisplatin—testicular cancer	0.000763	0.00454	CcSEcCtD
Primidone—Diplopia—Doxorubicin—testicular cancer	0.00076	0.00452	CcSEcCtD
Primidone—Nausea—Vinblastine—testicular cancer	0.00075	0.00446	CcSEcCtD
Primidone—Anorexia—Cisplatin—testicular cancer	0.000749	0.00445	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000746	0.00443	CcSEcCtD
Primidone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000716	0.00426	CcSEcCtD
Primidone—Ataxia—Doxorubicin—testicular cancer	0.000715	0.00425	CcSEcCtD
Primidone—Asthenia—Dactinomycin—testicular cancer	0.000714	0.00424	CcSEcCtD
Primidone—Skin disorder—Etoposide—testicular cancer	0.000699	0.00416	CcSEcCtD
Primidone—Anorexia—Etoposide—testicular cancer	0.000686	0.00408	CcSEcCtD
Primidone—Decreased appetite—Cisplatin—testicular cancer	0.000683	0.00406	CcSEcCtD
Primidone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000679	0.00403	CcSEcCtD
Primidone—Vomiting—Bleomycin—testicular cancer	0.000678	0.00403	CcSEcCtD
Primidone—Drowsiness—Methotrexate—testicular cancer	0.000676	0.00402	CcSEcCtD
Primidone—Depression—Methotrexate—testicular cancer	0.000674	0.00401	CcSEcCtD
Primidone—Rash—Bleomycin—testicular cancer	0.000673	0.004	CcSEcCtD
Primidone—Dermatitis—Bleomycin—testicular cancer	0.000672	0.00399	CcSEcCtD
Primidone—Asthenia—Ifosfamide—testicular cancer	0.000654	0.00389	CcSEcCtD
Primidone—Somnolence—Etoposide—testicular cancer	0.00064	0.00381	CcSEcCtD
Primidone—Nausea—Bleomycin—testicular cancer	0.000634	0.00377	CcSEcCtD
Primidone—Drowsiness—Epirubicin—testicular cancer	0.000633	0.00376	CcSEcCtD
Primidone—Vomiting—Dactinomycin—testicular cancer	0.000633	0.00376	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—testicular cancer	0.000631	0.00375	CcSEcCtD
Primidone—Rash—Dactinomycin—testicular cancer	0.000627	0.00373	CcSEcCtD
Primidone—Decreased appetite—Etoposide—testicular cancer	0.000626	0.00372	CcSEcCtD
Primidone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000622	0.0037	CcSEcCtD
Primidone—Fatigue—Etoposide—testicular cancer	0.000621	0.00369	CcSEcCtD
Primidone—Dizziness—Ifosfamide—testicular cancer	0.000603	0.00358	CcSEcCtD
Primidone—Nausea—Dactinomycin—testicular cancer	0.000591	0.00351	CcSEcCtD
Primidone—Agranulocytosis—Epirubicin—testicular cancer	0.000591	0.00351	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—testicular cancer	0.000586	0.00348	CcSEcCtD
Primidone—Visual impairment—Methotrexate—testicular cancer	0.000585	0.00348	CcSEcCtD
Primidone—Vomiting—Ifosfamide—testicular cancer	0.00058	0.00345	CcSEcCtD
Primidone—Rash—Ifosfamide—testicular cancer	0.000575	0.00342	CcSEcCtD
Primidone—Dermatitis—Ifosfamide—testicular cancer	0.000574	0.00341	CcSEcCtD
Primidone—Eye disorder—Methotrexate—testicular cancer	0.000567	0.00337	CcSEcCtD
Primidone—Asthenia—Cisplatin—testicular cancer	0.000564	0.00335	CcSEcCtD
Primidone—Connective tissue disorder—Epirubicin—testicular cancer	0.000558	0.00332	CcSEcCtD
Primidone—Visual impairment—Epirubicin—testicular cancer	0.000548	0.00325	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—testicular cancer	0.000546	0.00325	CcSEcCtD
Primidone—Nausea—Ifosfamide—testicular cancer	0.000542	0.00322	CcSEcCtD
Primidone—Mental disorder—Methotrexate—testicular cancer	0.000532	0.00316	CcSEcCtD
Primidone—Eye disorder—Epirubicin—testicular cancer	0.000531	0.00316	CcSEcCtD
Primidone—Malnutrition—Methotrexate—testicular cancer	0.000528	0.00314	CcSEcCtD
Primidone—Asthenia—Etoposide—testicular cancer	0.000517	0.00307	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000517	0.00307	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—testicular cancer	0.000507	0.00301	CcSEcCtD
Primidone—Vomiting—Cisplatin—testicular cancer	0.0005	0.00297	CcSEcCtD
Primidone—Mental disorder—Epirubicin—testicular cancer	0.000498	0.00296	CcSEcCtD
Primidone—Rash—Cisplatin—testicular cancer	0.000496	0.00295	CcSEcCtD
Primidone—Dermatitis—Cisplatin—testicular cancer	0.000495	0.00294	CcSEcCtD
Primidone—Malnutrition—Epirubicin—testicular cancer	0.000495	0.00294	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—testicular cancer	0.000491	0.00292	CcSEcCtD
Primidone—Anaemia—Methotrexate—testicular cancer	0.000488	0.0029	CcSEcCtD
Primidone—Dizziness—Etoposide—testicular cancer	0.000476	0.00283	CcSEcCtD
Primidone—Vertigo—Methotrexate—testicular cancer	0.000475	0.00282	CcSEcCtD
Primidone—Nausea—Cisplatin—testicular cancer	0.000467	0.00278	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—testicular cancer	0.000461	0.00274	CcSEcCtD
Primidone—Vomiting—Etoposide—testicular cancer	0.000458	0.00272	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—testicular cancer	0.000458	0.00272	CcSEcCtD
Primidone—Anaemia—Epirubicin—testicular cancer	0.000457	0.00272	CcSEcCtD
Primidone—Rash—Etoposide—testicular cancer	0.000454	0.0027	CcSEcCtD
Primidone—Dermatitis—Etoposide—testicular cancer	0.000454	0.0027	CcSEcCtD
Primidone—Headache—Etoposide—testicular cancer	0.000451	0.00268	CcSEcCtD
Primidone—Arthralgia—Methotrexate—testicular cancer	0.00045	0.00267	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000447	0.00266	CcSEcCtD
Primidone—Vertigo—Epirubicin—testicular cancer	0.000444	0.00264	CcSEcCtD
Primidone—Nausea—Etoposide—testicular cancer	0.000428	0.00254	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—testicular cancer	0.000423	0.00251	CcSEcCtD
Primidone—Anaemia—Doxorubicin—testicular cancer	0.000423	0.00251	CcSEcCtD
Primidone—Arthralgia—Epirubicin—testicular cancer	0.000421	0.0025	CcSEcCtD
Primidone—Skin disorder—Methotrexate—testicular cancer	0.000419	0.00249	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000418	0.00249	CcSEcCtD
Primidone—Vertigo—Doxorubicin—testicular cancer	0.000411	0.00244	CcSEcCtD
Primidone—Anorexia—Methotrexate—testicular cancer	0.000411	0.00244	CcSEcCtD
Primidone—Nervous system disorder—Epirubicin—testicular cancer	0.000396	0.00235	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000393	0.00234	CcSEcCtD
Primidone—Skin disorder—Epirubicin—testicular cancer	0.000392	0.00233	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—testicular cancer	0.00039	0.00232	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000387	0.0023	CcSEcCtD
Primidone—Anorexia—Epirubicin—testicular cancer	0.000385	0.00229	CcSEcCtD
Primidone—Somnolence—Methotrexate—testicular cancer	0.000383	0.00228	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—testicular cancer	0.000375	0.00223	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000372	0.00221	CcSEcCtD
Primidone—Fatigue—Methotrexate—testicular cancer	0.000372	0.00221	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000368	0.00219	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—testicular cancer	0.000366	0.00218	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—testicular cancer	0.000363	0.00216	CcSEcCtD
Primidone—Somnolence—Epirubicin—testicular cancer	0.000359	0.00213	CcSEcCtD
Primidone—Anorexia—Doxorubicin—testicular cancer	0.000356	0.00212	CcSEcCtD
Primidone—Decreased appetite—Epirubicin—testicular cancer	0.000351	0.00209	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000348	0.00207	CcSEcCtD
Primidone—Fatigue—Epirubicin—testicular cancer	0.000348	0.00207	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00034	0.00202	CcSEcCtD
Primidone—Somnolence—Doxorubicin—testicular cancer	0.000332	0.00197	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—testicular cancer	0.000325	0.00193	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000322	0.00192	CcSEcCtD
Primidone—Fatigue—Doxorubicin—testicular cancer	0.000322	0.00191	CcSEcCtD
Primidone—Asthenia—Methotrexate—testicular cancer	0.000309	0.00184	CcSEcCtD
Primidone—Asthenia—Epirubicin—testicular cancer	0.00029	0.00172	CcSEcCtD
Primidone—Dizziness—Methotrexate—testicular cancer	0.000285	0.0017	CcSEcCtD
Primidone—Vomiting—Methotrexate—testicular cancer	0.000274	0.00163	CcSEcCtD
Primidone—Rash—Methotrexate—testicular cancer	0.000272	0.00162	CcSEcCtD
Primidone—Dermatitis—Methotrexate—testicular cancer	0.000272	0.00162	CcSEcCtD
Primidone—Headache—Methotrexate—testicular cancer	0.00027	0.00161	CcSEcCtD
Primidone—Asthenia—Doxorubicin—testicular cancer	0.000268	0.00159	CcSEcCtD
Primidone—Dizziness—Epirubicin—testicular cancer	0.000267	0.00159	CcSEcCtD
Primidone—Vomiting—Epirubicin—testicular cancer	0.000257	0.00153	CcSEcCtD
Primidone—Nausea—Methotrexate—testicular cancer	0.000256	0.00152	CcSEcCtD
Primidone—Rash—Epirubicin—testicular cancer	0.000255	0.00151	CcSEcCtD
Primidone—Dermatitis—Epirubicin—testicular cancer	0.000254	0.00151	CcSEcCtD
Primidone—Headache—Epirubicin—testicular cancer	0.000253	0.0015	CcSEcCtD
Primidone—Dizziness—Doxorubicin—testicular cancer	0.000247	0.00147	CcSEcCtD
Primidone—Nausea—Epirubicin—testicular cancer	0.00024	0.00143	CcSEcCtD
Primidone—Vomiting—Doxorubicin—testicular cancer	0.000237	0.00141	CcSEcCtD
Primidone—Rash—Doxorubicin—testicular cancer	0.000235	0.0014	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—testicular cancer	0.000235	0.0014	CcSEcCtD
Primidone—Headache—Doxorubicin—testicular cancer	0.000234	0.00139	CcSEcCtD
Primidone—Nausea—Doxorubicin—testicular cancer	0.000222	0.00132	CcSEcCtD
